In women with borderline personality disorder and healthy controls, intranasal oxytocin 24 I.U. had no significant effect on mean HRV versus placebo.
In plain wordsIn women with borderline personality disorder and healthy women, oxytocin did not change heart-rate variability compared with placebo.
- Peptide
- Oxytocin
- Outcome
- No significant changeMean heart-rate variability (HRV)
- Study
n = 113
- Comparator
- Placebo
- Outcome group
- Heart function · Cardiovascular
- Studied dose
- 24 I.U. · intranasalAs given in this study (human).
Source sentences
our results do not support a significant effect of oxytocin on mean HRV, and no interaction effect emerged including childhood trauma and attachment insecurity.
1 context sentence(design, population, supporting numbers)
In a randomized, placebo-controlled trial, 53 unmedicated women with BPD and 60 healthy controls (HC) self-administered either 24 I.U. of oxytocin or placebo and underwent a 4-min electrocardiogram.